Multidrug efflux systems in Gram-negative bacteria
Multidrug efflux mechanisms in bacteria contribute significantly to intrinsic and acquired resistance to antimicrobial agents. Genome analysis have confirmed the broad distribution of these systems in Gram-negative as well as in Gram-positive bacteria. Among resistance mechanisms, the multidrug efflux system or pump deserves special attention, since a cell that has acquired it can simultaneously diminish or even suppress the susceptibility to a wide range of antimicrobials. The efflux system is mediated by transport proteins which confer resistance to toxic compounds. In Gram-negative bacteria, a tripartite efflux system is necessary to expel the drug to the outer medium: a protein localized in the cytoplasmic membrane; another in the periplasmatic space (membrane fusion protein - MFP); and a third in the outer membrane (outer membrane factor - OMF). The drug transport is active, and depends either on the energy provided by ATP hydrolysis or is directly driven by the proton motive force. The transport proteins are grouped in families, according to the homology of the amino acid sequences and to similarity of mechanisms. Among Gram-negative bacteria, Escherichia coli and Pseudomonas aeruginosa have most of the hitherto identified and studied multidrug efflux systems.
Main Authors: | Moreira,Maria Aparecida Scatamburlo, Souza,Edmar Chartone de, Moraes,Célia Alencar de |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Microbiologia
2004
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822004000100003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends of 9,416 multidrug-resistant Gram-negative bacteria
by: Oliveira,Viviane Decicera Colombo, et al.
Published: (2015) -
Multidrug efflux systems in Escherichia coli and Enterobacter cloacae obtained from wholesome broiler carcasses
by: Moreira,Maria Aparecida S., et al.
Published: (2009) -
The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19
by: de Macedo,Viviane, et al.
Published: (2022) -
Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes
by: Costa,Patrícia de Oliveira, et al.
Published: (2015) -
Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria
by: Wang, J., et al.
Published: (2020-11)